Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Latika Nirola"'
Publikováno v:
Case Reports in Neurological Medicine, Vol 2021 (2021)
Patients receiving complement inhibitor, eculizumab, are at high risk for infections with encapsulated organisms such as Neisseria due to impaired opsonophagocytic activity. Impaired complement immunity may increase the risk for dissemination of asym
Externí odkaz:
https://doaj.org/article/dbebe57cbac14aa4997618f958ed2720